$LMAT
LEMAITRE VASCULAR INC Stock $lmat

$lmat Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924015899 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$55.85M	$53.48M
YoY Change	11.44%	13.6%
Cost Of Revenue	$17.38M	$16.81M
YoY Change	-3.59%	3.84%
Gross Profit	$38.47M	$36.67M
YoY Change	19.89%	18.72%
Gross Profit Margin	68.88%	68.56%
Selling, General & Admin	$19.80M	$20.70M
YoY Change	10.4%	9.93%
% of Gross Profit	51.48%	56.45%
Research & Development	$4.284M	$4.092M
YoY Change	-5.14%	5.6%
% of Gross Profit	11.14%	11.16%
Depreciation & Amortization	$2.384M	$2.382M
YoY Change	2.49%	1.32%
% of Gross Profit	6.2%	6.5%
Operating Expenses	$24.09M	$24.79M
YoY Change	7.28%	9.19%
Operating Profit	$14.38M	$11.87M
YoY Change	49.29%	45.18%
Interest Expense	$1.126M	$923.0K
YoY Change	29.87%	545.45%
% of Operating Profit	7.83%	7.77%
Other Income/Expense, Net
YoY Change
Pretax Income	$15.51M	$12.80M
YoY Change	50.27%	59.62%
Income Tax	$3.680M	$2.910M
% Of Pretax Income	23.73%	22.74%
Net Earnings	$11.83M	$9.887M
YoY Change	46.04%	63.69%
Net Earnings / Revenue	21.17%	18.49%
Basic Earnings Per Share	$0.53	$0.44
Diluted Earnings Per Share	$0.52	$0.44
COMMON SHARES
Basic Shares Outstanding	22.45M	22.34M
Diluted Shares Outstanding	22.73M	22.57M

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$113.1M	$108.3M
YoY Change	25.42%	33.68%
Cash & Equivalents	$22.27M	$26.60M
Short-Term Investments	$90.83M	$81.69M
Other Short-Term Assets	$5.217M	$3.863M
YoY Change	27.99%	-16.37%
Inventory	$63.67M	$60.58M
Prepaid Expenses
Receivables	$30.82M	$30.24M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$212.8M	$203.0M
YoY Change	21.96%	23.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.12M	$39.97M
YoY Change	-37.56%	14.96%
Goodwill	$65.95M	$65.95M
YoY Change	0.0%	0.0%
Intangibles	$38.77M	$40.24M
YoY Change	-11.89%	-11.58%
Long-Term Investments
YoY Change
Other Assets	$4.117M	$4.842M
YoY Change	-17.86%	24.92%
Total Long-Term Assets	$150.3M	$151.0M
YoY Change	-1.12%	0.6%
TOTAL ASSETS
Total Short-Term Assets	$212.8M	$203.0M
Total Long-Term Assets	$150.3M	$151.0M
Total Assets	$363.1M	$354.0M
YoY Change	11.21%	12.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.995M	$3.089M
YoY Change	-43.31%	-8.37%
Accrued Expenses	$20.79M	$23.65M
YoY Change	-4.15%	20.17%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$25.45M	$26.81M
YoY Change	-1.58%	12.16%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$2.179M	$18.53M
YoY Change	-86.96%	10.79%
Total Long-Term Liabilities	$2.179M	$18.53M
YoY Change	-86.96%	10.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.45M	$26.81M
Total Long-Term Liabilities	$2.179M	$18.53M
Total Liabilities	$43.55M	$45.45M
YoY Change	2.13%	11.68%
SHAREHOLDERS EQUITY
Retained Earnings	$130.0M	$121.7M
YoY Change	22.96%	20.87%
Common Stock	$208.9M	$206.6M
YoY Change	5.96%	7.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$319.5M	$308.5M
YoY Change
Total Liabilities & Shareholders Equity	$363.1M	$354.0M
YoY Change	11.21%	12.42%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$11.83M	$9.887M
YoY Change	46.04%	63.69%
Depreciation, Depletion And Amortization	$2.384M	$2.382M
YoY Change	2.49%	1.32%
Cash From Operating Activities	$9.625M	$5.071M
YoY Change	-19.14%	122.51%
INVESTING ACTIVITIES
Capital Expenditures	$1.878M	$1.370M
YoY Change	-33.0%	-35.68%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$9.125M	-$991.0K
YoY Change	33.48%	18.82%
Cash From Investing Activities	-$11.00M	-$2.361M
YoY Change	14.15%	-20.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.870M	$39.00K
YoY Change	-671.71%	-102.14%
NET CHANGE
Cash From Operating Activities	9.625M	$5.071M
Cash From Investing Activities	-11.00M	-$2.361M
Cash From Financing Activities	-2.870M	$39.00K
Net Change In Cash	-4.248M	$2.326M
YoY Change	-253.58%	-194.67%
FREE CASH FLOW
Cash From Operating Activities	$9.625M	$5.071M
Capital Expenditures	$1.878M	$1.370M
Free Cash Flow	$7.747M	$3.701M
YoY Change	-14.87%	2383.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	53478000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	47075000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	9887000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6040000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22111000
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001158895
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3734000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23650000	usd
CY2023Q4	lmat	Acquisition Related Obligations AcquisitionRelatedObligations	24000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2471000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	29879000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16624000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	107000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2268000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	48878000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	3000000
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	37000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23911760
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	239000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	200755000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	115430000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4625000	usd
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1584512
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	13899000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	297900000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	346778000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	36665000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	11686000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10897000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9013000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7932000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4092000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3875000	usd
CY2024Q1	us-gaap	Restructuring Costs RestructuringCosts	0	usd
CY2023Q1	us-gaap	Restructuring Costs RestructuringCosts	305000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	24791000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	23009000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	11874000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	7874000	usd
CY2024Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1001000	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	568000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-78000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-425000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12797000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8017000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2910000	usd
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3099000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	172000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1977000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	9887000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6040000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22365000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22111000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22570000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22274000
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.16
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.14
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	9887000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6040000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-831000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	252000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-102000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	207000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-933000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	459000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8954000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6499000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	268201000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6040000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	459000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1446000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1290000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	274165000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	297900000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	9887000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-933000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3986000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	358000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1610000	usd
CY2024Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3589000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	308503000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	9887000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6040000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2382000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2351000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1610000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1290000	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	716000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	334000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	362000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-7000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	23000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	25000	usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-0	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-305000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	45000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-54000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5750000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3242000	usd
CY2024Q1	lmat	Increase Decrease In Inventory And Other Deferred Costs IncreaseDecreaseInInventoryAndOtherDeferredCosts	3537000	usd
CY2023Q1	lmat	Increase Decrease In Inventory And Other Deferred Costs IncreaseDecreaseInInventoryAndOtherDeferredCosts	3755000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2216000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1224000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-2793000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Other Operating Liabilities IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities	-2340000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5071000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2279000	usd
CY2024Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1370000	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	2130000	usd
CY2024Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	991000	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	564000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-0	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	270000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2361000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2964000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3986000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1446000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	358000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	172000	usd
CY2024Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3589000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3099000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	39000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1825000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-423000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	53000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2326000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2457000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24269000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19134000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26595000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	16677000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	53478000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47075000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	525000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	587000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	22000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	-0	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	40000	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	525000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	20813000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	18333000	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2532000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2869000	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	31148000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	31131000	usd
CY2024Q1	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	6082000	usd
CY2023Q4	us-gaap	Other Inventory Capitalized Costs OtherInventoryCapitalizedCosts	5747000	usd
CY2024Q1	lmat	Inventory And Other Deferred Costs InventoryAndOtherDeferredCosts	60575000	usd
CY2023Q4	lmat	Inventory And Other Deferred Costs InventoryAndOtherDeferredCosts	58080000	usd
CY2024Q1	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	2200000	usd
CY2023Q4	us-gaap	Other Inventory Materials Supplies And Merchandise Under Consignment OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment	2000000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	3100000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0495	pure
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	72130000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	31891000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	40239000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	72130000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	30419000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	41711000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1472000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1559000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	4385000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	5601000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5119000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	4842000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	4456000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4423000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	740000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	580000	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	29000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	162000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	769000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	742000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	1022000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	737000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	509000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	472000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y6M
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M12D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.066	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2758000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3488000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2806000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2567000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	2535000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2481000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	8495000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	6248000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	18882000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7770000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	13353000	usd
CY2024Q1	lmat	Accrued Purchases Current AccruedPurchasesCurrent	7478000	usd
CY2023Q4	lmat	Accrued Purchases Current AccruedPurchasesCurrent	5152000	usd
CY2024Q1	lmat	Accrued Expenses Current AccruedExpensesCurrent	4503000	usd
CY2023Q4	lmat	Accrued Expenses Current AccruedExpensesCurrent	4251000	usd
CY2024Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	708000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	390000	usd
CY2024Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	83000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	104000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	576000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	400000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	21118000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	23650000	usd
CY2024Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities	1354000	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities	1406000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	594000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	637000	usd
CY2024Q1	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	228000	usd
CY2023Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	225000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2176000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2268000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1610000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1290000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1610000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1290000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	222
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	200
CY2024Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	125000
CY2023Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	59000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	9887000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	6040000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22365000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22111000
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22365000
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	205000
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	163000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22570000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22274000
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.44
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	175000
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	320000
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1396000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	271000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1224000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1339000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-0	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	-0	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-23000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-20000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1247000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	1359000	usd

Files In Submission

Name	View Source	Status
0001437749-24-015899-index-headers.html	Edgar Link	pending
0001437749-24-015899-index.html	Edgar Link	pending
0001437749-24-015899.txt	Edgar Link	pending
0001437749-24-015899-xbrl.zip	Edgar Link	pending
ex_667565.htm	Edgar Link	pending
ex_667566.htm	Edgar Link	pending
ex_667567.htm	Edgar Link	pending
ex_667568.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lmat-20240331.xsd	Edgar Link	pending
lmat20240331_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
lmat-20240331_cal.xml	Edgar Link	unprocessable
lmat-20240331_def.xml	Edgar Link	unprocessable
lmat-20240331_lab.xml	Edgar Link	unprocessable
lmat-20240331_pre.xml	Edgar Link	unprocessable
lmat20240331_10q_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LMAT
LEMAITRE VASCULAR INC Stock $lmat

2024 Q2 Form 10-Q Financial Statement

#000143774924015899 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LMAT LEMAITRE VASCULAR INC Stock $lmat

2024 Q2 Form 10-Q Financial Statement

#000143774924015899 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LMAT
LEMAITRE VASCULAR INC Stock $lmat